SONM
DNA X, Inc.
$4.74
+0.85%
$7.1M
No data for this timeframe.
Vol
Market Cap$7.1M
Cap SizeNano Cap
Inst. Holders4 funds
Inst. Value$94.3K
SEC Reports5
Recent Activity
Jun 12, 2026
SEC
DNA X, Inc. (ticker SONM) received SEC effectiveness on June 11, 2026 for its registration statement on Form S-3 (File N
EFFECT — Impact 6/10
Jun 4, 2026
SEC
DNA X, Inc. terminated its ChEF Purchase Agreement with Chardan Capital Markets, which had committed up to $500 million
8-K — Impact 4/10
May 27, 2026
SEC
DNA X, Inc. (SONM) disclosed a Nasdaq delisting determination due to a stockholders' deficit of $983,000, violating the
8-K — Impact 8/10
May 13, 2026
earnings_calendar
SONM Q1 2026 Earnings Scheduled — 2026-05-13
Feb 9, 2026
Insider
MULICA MICHAEL C was granted 50,000 shares
Acting CEO
Feb 9, 2026
Insider
Crolius Clayton was granted 35,000 shares
Chief Financial Officer
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Latest Reports
BEARISH
EFFECT
6/10
DNA X, Inc. (ticker SONM) received SEC effectiveness on June 11, 2026 for its registration statement on Form S-3 (File N
Jun 12, 2026
NEUTRAL
8-K
4/10
DNA X, Inc. terminated its ChEF Purchase Agreement with Chardan Capital Markets, which had committed up to $500 million
Jun 4, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $56.4K | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $19.7K | — |
| VANGUARD FIDUCIARY TRUST CO | $18.1K | — |
| DANSKE BANK A/S | $16.00 | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Feb 9, 2026 | MULICA MICHAEL | A | $0.00 |
| Feb 9, 2026 | Crolius Clayton | A | $0.00 |
4 institutional holders with $94.3K total value (23,398 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 14,006 | $56.4K | 59.9% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4,892 | $19.7K | 20.9% | — |
| 3 | VANGUARD FIDUCIARY TRUST CO | 4,496 | $18.1K | 19.2% | — |
| 4 | DANSKE BANK A/S | 4 | $16.00 | 0.0% | — |
2 unique insiders with 2 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | MULICA MICHAEL C | Acting CEO | AWARD | 50,000 | — | — |
| Feb 9, 2026 | Crolius Clayton | Chief Financial Officer | AWARD | 35,000 | — | — |
5 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 2 neutral. Avg impact: 6.0/10.
BEARISH
EFFECT
6/10
DNA X, Inc. (ticker SONM) received SEC effectiveness on June 11, 2026 for its registration statement
Jun 12, 2026
NEUTRAL
8-K
4/10
DNA X, Inc. terminated its ChEF Purchase Agreement with Chardan Capital Markets, which had committed
Jun 4, 2026
BEARISH
8-K
8/10
DNA X, Inc. (SONM) disclosed a Nasdaq delisting determination due to a stockholders' deficit of $983
May 27, 2026
BEARISH
8-K, 10-K/A
7/10
DNA X, Inc. (SONM) dismissed its auditor Baker Tilly and engaged TAAD LLP as its new independent reg
Apr 30, 2026
NEUTRAL
8-K
5/10
DNA X, Inc. (formerly Sonim Technologies) reported its full-year 2025 financial results, marking a c
Apr 15, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2025-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2024 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Dec 1, 2023 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 13, 2026
earnings_calendar
SONM Q1 2026 Earnings Scheduled — 2026-05-13
May 11, 2026
earnings_calendar
SONM Q1 2026 Earnings Scheduled — 2026-05-11
Mar 30, 2026
earnings_calendar
SONM Q4 2025 Earnings After Market Close — 2026-03-30
Mar 27, 2026
short_volume
Short Volume: SONM — 64.2% short (0.3M / 0.5M)
Short: 330,717 | Exempt: 1,205 | TRF Vol: 515,154 | Short Ratio: 64.2% | Off-exchange volume (dark pool + OTC)